RDNT

RadNet Inc
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$5.41B
P/E Ratio
—
EPS
$-0.26
Beta
1.41
52W High
$85.84
52W Low
$50.82
50-Day MA
$73.50
200-Day MA
$65.34
Dividend Yield
—
Profit Margin
-0.93%
Forward P/E
36.63
PEG Ratio
0.96

About RadNet Inc

RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.27B
Gross Profit (TTM)$392.17M
EBITDA$276.15M
Operating Margin7.89%
Return on Equity1.50%
Return on Assets1.70%
Revenue/Share (TTM)$29.52
Book Value$13.94
Price-to-Book5.31
Price-to-Sales (TTM)2.39
EV/Revenue3.208
EV/EBITDA21.58
Quarterly Earnings Growth (YoY)-49.10%
Quarterly Revenue Growth (YoY)25.00%
Shares Outstanding$78.70M
Float$65.76M
% Insiders9.96%
% Institutions105.56%

Historical Volatility

HV 10-Day
34.42%
HV 20-Day
35.23%
HV 30-Day
36.15%
HV 60-Day
37.78%
HV Rank
28.6%

Volatility is currently contracting

Analyst Ratings

Consensus ($94.62 target)
2
Strong Buy
6
Buy

Latest News

New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies

SOMERVILLE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced new findings published in European Radiology supporting that AI applications within DeepHealth's Prostate MR Solution1 could help clinicians decide more confidently which men may need a prostate biopsy, particularly when MRI findings are uncertain.2 Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in 2024.3 MRI helps clinicians assess whether prostate cancer may be present, but some findings remain uncertain.4   A biopsy involves collecting small tissue samples to check for cancer and, if found, assess its grade.

GlobeNewsWire10/8/2026Neutral
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026 at 07:45 a.m. Eastern Time.

GlobeNewsWire9/9/2026Neutral
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, September 19, 2026, in support of Prostate Cancer Awareness Month.

GlobeNewsWire9/9/2026Neutral
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026

LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Greg Sorensen, Executive Vice President and Chief Strategy Officer, will be presenting at the Jefferies Healthcare Services Conference on Tuesday, September 15, 2026 at 9:10 a.m.

GlobeNewsWire9/8/2026Neutral
RadNet: Imaging And AI Keep The Bull Case Intact

RDNT's advanced imaging mix is expanding. I think this will continue to support its improving revenue quality and margins. RDNT's joint ventures across healthcare systems also help it deepen its integration across customers' workflows. DeepHealth is RDNT's second growth leg, as it pairs external software sales with internal workflow efficiencies.

Seeking Alpha8/12/2026Positive
RadNet Q2 Earnings Call Highlights

RadNet NASDAQ: RDNT reported record quarterly revenue and adjusted EBITDA for the second quarter of 2026, supported by higher imaging volumes, acquisitions, a shift toward advanced imaging procedures and growth in its Digital Health segment.

MarketBeat8/10/2026Neutral
RadNet (RDNT) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for RadNet (RDNT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research8/10/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RDNT and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026